Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer

NCT02354131 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
108
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Nordic Society of Gynaecological Oncology - Clinical Trials Unit

Collaborators